According to Aurinia Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -395.14%. At the end of 2021 the company had an Operating Margin of -395.15%.
Year | Operating Margin | Change |
---|---|---|
2021 | -395.15% | 92.69% |
2020 | -205.06% | -99.47% |
2019 | -38,900.00% | 181.21% |
2018 | -13,833.05% | -17.93% |
2017 | -16,855.24% | 25.18% |
2016 | -13,465.32% | 70.06% |
2015 | -7,917.87% | 32.23% |
2014 | -5,988.13% | 787.2% |
2013 | -674.95% | 326.79% |
2012 | -158.15% | -39.07% |
2011 | -259.56% | 62.63% |
2010 | -159.60% | -28.28% |
2009 | -222.53% | -44.77% |
2008 | -402.88% | -72.19% |
2007 | -1,448.70% | 123.3% |
2006 | -648.76% | -73.72% |
2005 | -2,468.35% | 39.37% |
2004 | -1,771.13% | 834.53% |
2003 | -189.52% | 7579.53% |
2002 | -2.47% | -98.22% |
2001 | -138.74% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Regeneron Pharmaceuticals REGN | 37.68% | -109.54% | ๐บ๐ธ USA |
Pieris Pharmaceuticals PIRS | -128.47% | -67.49% | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | -161.15% | -59.22% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.